PL2454266T3 - Sól cytrynianowa 9E-15-(2-pirolidyn-1-ylo-etoksy)-7,12,25-trioksa-19,21,24-triaza-tetracyklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaenu - Google Patents

Sól cytrynianowa 9E-15-(2-pirolidyn-1-ylo-etoksy)-7,12,25-trioksa-19,21,24-triaza-tetracyklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaenu

Info

Publication number
PL2454266T3
PL2454266T3 PL10737645T PL10737645T PL2454266T3 PL 2454266 T3 PL2454266 T3 PL 2454266T3 PL 10737645 T PL10737645 T PL 10737645T PL 10737645 T PL10737645 T PL 10737645T PL 2454266 T3 PL2454266 T3 PL 2454266T3
Authority
PL
Poland
Prior art keywords
nonaene
hexacosa
trioxa
tetracyclo
triaza
Prior art date
Application number
PL10737645T
Other languages
English (en)
Polish (pl)
Inventor
Brian Dymock
Cheng Hsia Angeline Lee
Anthony Deodaunia William
Original Assignee
Cell Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Therapeutics Inc filed Critical Cell Therapeutics Inc
Publication of PL2454266T3 publication Critical patent/PL2454266T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL10737645T 2009-07-15 2010-07-14 Sól cytrynianowa 9E-15-(2-pirolidyn-1-ylo-etoksy)-7,12,25-trioksa-19,21,24-triaza-tetracyklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaenu PL2454266T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22560909P 2009-07-15 2009-07-15
EP10737645.1A EP2454266B1 (en) 2009-07-15 2010-07-14 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt
PCT/SG2010/000265 WO2011008172A1 (en) 2009-07-15 2010-07-14 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt

Publications (1)

Publication Number Publication Date
PL2454266T3 true PL2454266T3 (pl) 2014-01-31

Family

ID=42790728

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10737645T PL2454266T3 (pl) 2009-07-15 2010-07-14 Sól cytrynianowa 9E-15-(2-pirolidyn-1-ylo-etoksy)-7,12,25-trioksa-19,21,24-triaza-tetracyklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaenu

Country Status (18)

Country Link
US (1) US9062074B2 (enExample)
EP (1) EP2454266B1 (enExample)
JP (2) JP6013911B2 (enExample)
CN (1) CN102762577B (enExample)
AR (2) AR077483A1 (enExample)
BR (1) BR112012000750B1 (enExample)
CA (1) CA2768210C (enExample)
DK (1) DK2454266T3 (enExample)
ES (1) ES2429525T3 (enExample)
HR (1) HRP20130941T1 (enExample)
MX (1) MX2012000680A (enExample)
PL (1) PL2454266T3 (enExample)
PT (1) PT2454266E (enExample)
RU (1) RU2543721C2 (enExample)
SI (1) SI2454266T1 (enExample)
SM (1) SMT201300112B (enExample)
TW (1) TWI537276B (enExample)
WO (1) WO2011008172A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2966753A1 (en) 2014-11-17 2016-05-26 Arno Therapeutics, Inc. Onapristone extended-release compositions and methods
AU2016326657B2 (en) 2015-09-25 2019-10-24 Context Biopharma, Inc. Methods of making onapristone intermediates
CA3008422A1 (en) 2015-12-15 2017-06-22 Context Biopharma Inc. Amorphous onapristone compositions and methods of making the same
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110603A (en) * 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
US7151096B2 (en) * 2003-03-05 2006-12-19 Irm Llc Cyclic compounds and compositions as protein kinase inhibitors
CN101365703B (zh) * 2005-11-16 2013-11-06 S*Bio私人有限公司 杂烷基连接的嘧啶衍生物

Also Published As

Publication number Publication date
CN102762577A (zh) 2012-10-31
AR114987A2 (es) 2020-11-11
EP2454266A1 (en) 2012-05-23
JP2012533539A (ja) 2012-12-27
WO2011008172A1 (en) 2011-01-20
CA2768210C (en) 2017-08-15
ES2429525T3 (es) 2013-11-15
AR077483A1 (es) 2011-08-31
HRP20130941T1 (hr) 2013-11-08
MX2012000680A (es) 2012-02-28
BR112012000750A8 (pt) 2018-02-06
TWI537276B (zh) 2016-06-11
EP2454266B1 (en) 2013-07-10
CA2768210A1 (en) 2011-01-20
SI2454266T1 (sl) 2013-10-30
BR112012000750B1 (pt) 2021-05-25
BR112012000750A2 (pt) 2016-08-09
SMT201300112B (it) 2013-11-08
JP2015164941A (ja) 2015-09-17
US9062074B2 (en) 2015-06-23
RU2012105044A (ru) 2013-08-20
HK1178159A1 (en) 2013-09-06
DK2454266T3 (da) 2013-09-08
TW201107336A (en) 2011-03-01
US20120196876A1 (en) 2012-08-02
RU2543721C2 (ru) 2015-03-10
JP6013911B2 (ja) 2016-10-25
CN102762577B (zh) 2015-01-07
PT2454266E (pt) 2013-10-10

Similar Documents

Publication Publication Date Title
IL215908A0 (en) Pyrrolo [2,3.b] pyridines which inhibit raf protein kinase
AP2012006216A0 (en) Benzimidazole-imidazole derivatives.
AP2012006192A0 (en) PyrroloÄ2,3-DÜ pyrimidine compounds.
SI2013208T1 (sl) Piridin(3,4-b)pirazinoni
AP3099A (en) Dioxa-bicyclo[3.2.1]octane-2,3,4-triol de derivatives
IL217918A0 (en) 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazine derivatives
SI2531492T1 (sl) Derivati 1,2,4-triazin-4-amina
ZA201107350B (en) Imidazo [2 1 b] [1, 3, 4] thiadiazole derivatives
ZA201206630B (en) Hetaryl-[1,8]naphthyridine derivatives
PL2531505T3 (pl) Sposób wytwarzania kompleksów 3,7-diaza-bicyklo[3.3.1]nonanu z metalami
ZA201204135B (en) 3,4,4a,10b-tetrahydro-1h-thiopyrano-[4.3-c]isoquinoline derivatives
ZA201404074B (en) 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives
EP2142542A4 (en) NEW IMIDAZO [4,5-B] PYRIDINE-7-CARBOXYLAMIDEAMIDE 704
IL221479A0 (en) Triazolo [4,5-b] pyridin derivatives
IL217656A (en) Method for producing 1,1,3-trichloro-1-propane
IL289379A (en) Citrate salt of 11-(2-pyrrolidin-1-yl-ethoxy)-19,14-dioxa-26,7,5-triaza-tetracyclo[1.1.3.19(6,2)1(12,8)]hepatacosa- 1(25),2(26),12,10,8,5,3(27)j23,21,16–Decan
SI2281801T1 (sl) Postopek za pridobivanje 3,3-diphenilpropilamina
PL2454266T3 (pl) Sól cytrynianowa 9E-15-(2-pirolidyn-1-ylo-etoksy)-7,12,25-trioksa-19,21,24-triaza-tetracyklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaenu
IL206666A0 (en) N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
AP2010005479A0 (en) Phospohorous pentoxide producing methods.
PL2376500T3 (pl) Sól maleinianowa 11-(2-pirrolidyn-1-yloetoksy)-14,19-dioksa-5,7,26 triazatetracyklo[19.3.1.1(2,6).1(8,12)]heptakosa-1(25),2(26),3,5,8,10,12(27),16,21,23-dekaenu
GB2476643B (en) 1,4-Dihydro-1,4-dioxonaphtalene derivatives as anticoagulants
IL217584A (en) Process for the preparation of 4,2-dioxotetrahydroporan-3-carboxylates
IL206668A0 (en) N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
IL219623A0 (en) [1,5]-diazocin derivatives